Literature DB >> 7665219

Determinants of plasma pepsinogen levels in a population at high risk for stomach cancer in Venezuela.

I Kato1, K Miki, N Muñoz, J H Vivas, G Lopez, S Peraza, E Carillo, D Castro, O Andrade, V Sanchez.   

Abstract

Determinants of plasma pepsinogens (PG) levels were studied in 1365 participants in a chemoprevention trial for gastric pre-cancerous lesions being conducted in Venezuela. Gastric biopsies, plasma samples and information on smoking and dietary habits were obtained at baseline examination. Both PG-I and PG-II levels increased progressively with the level of Helicobacter pylori infection in gastric biopsies, resulting in no clear trend in the I/II ratio. Instead, there was a progressive decrease in the I/II ratio with increasing degrees of infiltration of polynuclear cells and monocytes, atrophy, intestinal metaplasia and the stage of pre-cancerous lesions. The mean I/II ratios for atrophic gastritis or more advanced lesions were less than 4.0. When subjects with the I/II ratio 4 or higher were used as controls, severe reduction in the I/II ratio (< 2.0) was inversely associated with tobacco consumption. This may be due to a pharmacological effect of nicotine. The severe reduction of I/II ratio was also inversely associated with fresh fruit consumption. In addition, a decreased I/II ratio was positively associated with rice/pasta and arepas (tortilla made from corn) consumption and inversely associated with plantain consumption. Possible effects of vitamins and starchy food on the development of atrophic gastritis need to be studied further.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665219     DOI: 10.1002/ijc.2910620504

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Gastric cancer screening using the serum pepsinogen test method.

Authors:  Kazumasa Miki
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

2.  Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma.

Authors:  Mário Dinis-Ribeiro; Altamiro da Costa-Pereira; Carlos Lopes; Joana Barbosa; Mateus Guilherme; Luís Moreira-Dias; Helena Lomba-Viana; Rui Silva; Nuno Abreu; Rafael Lomba-Viana
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

Review 3.  Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".

Authors:  Kazumasa Miki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

4.  The Impact of Gastric Atrophy on the Incidence of Diabetes.

Authors:  Tse-Ya Yu; Jung-Nan Wei; Chun-Heng Kuo; Jyh-Ming Liou; Mao-Shin Lin; Shyang-Rong Shih; Cyue-Huei Hua; Yenh-Chen Hsein; Ya-Wen Hsu; Lee-Ming Chuang; Mei-Kuei Lee; Ching-Hsiang Hsiao; Ming-Shiang Wu; Hung-Yuan Li
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

5.  Low pepsinogen I level predicts multiple gastric epithelial neoplasias for endoscopic resection.

Authors:  Seon Young Park; Sung Ook Lim; Ho Seok Ki; Chung Hwan Jun; Chang Hwan Park; Hyun Soo Kim; Sung Kyu Choi; Jong Sun Rew
Journal:  Gut Liver       Date:  2014-05       Impact factor: 4.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.